- Filed
- Mar 26, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Mar 25, 2026 | 84.65M sh |
| Shares Diluted | FY 2025 · Dec 31, 2025 | 62.39M sh |
| Shares Diluted restated | FY 2025 · Dec 31, 2024 | 54.98M sh |
| Capex | FY 2025 · Dec 31, 2025 | $1.17M |
| Capex | FY 2025 · Dec 31, 2024 | $556K |
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | −$24.32M |
| Operating Cash Flow | FY 2025 · Dec 31, 2024 | −$20.79M |
| Cash And Equivalents | FY 2025 · Dec 31, 2025 | $16.23M |
| Cash And Equivalents | FY 2025 · Dec 31, 2024 | $18.35M |
| Stockholders Equity | FY 2025 · Dec 31, 2025 | $15.73M |
| Stockholders Equity | FY 2025 · Dec 31, 2024 | $17.61M |
| Stockholders Equity | FY 2025 · Dec 31, 2023 | $20.76M |
| Current Liabilities | FY 2025 · Dec 31, 2025 | $6.6M |
| Current Liabilities | FY 2025 · Dec 31, 2024 | $5.99M |
| Total Liabilities | FY 2025 · Dec 31, 2025 | $23.66M |
| Total Liabilities | FY 2025 · Dec 31, 2024 | $23.95M |
| Current Assets | FY 2025 · Dec 31, 2025 | $17.9M |
| Current Assets | FY 2025 · Dec 31, 2024 | $20.44M |
| Total Assets | FY 2025 · Dec 31, 2025 | $39.39M |
| Total Assets | FY 2025 · Dec 31, 2024 | $41.56M |
| Eps Diluted | FY 2025 · Dec 31, 2025 | −$0.43 |
| Eps Diluted | FY 2025 · Dec 31, 2024 | −$0.43 |
| Eps Basic | FY 2025 · Dec 31, 2025 | −$0.43 |
| Eps Basic | FY 2025 · Dec 31, 2024 | −$0.43 |
| Sga Expense | FY 2025 · Dec 31, 2025 | $9.43M |
| Sga Expense | FY 2025 · Dec 31, 2024 | $8.93M |
| Rd Expense | FY 2025 · Dec 31, 2025 | $18.13M |
| Rd Expense | FY 2025 · Dec 31, 2024 | $15.75M |
| Net Income | FY 2025 · Dec 31, 2025 | −$26.61M |
| Net Income | FY 2025 · Dec 31, 2024 | −$23.49M |
| Operating Income | FY 2025 · Dec 31, 2025 | −$27.56M |
| Operating Income | FY 2025 · Dec 31, 2024 | −$24.68M |